Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 34.04% vs -15.22% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 918.75% vs -94.12% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 85.02% vs -55.40% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -100.00% vs 1,200.00% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Xvivo Perfusion AB With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -0.83% vs 6.59% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 34.04% vs -15.22% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -55.10% vs 14.87% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 918.75% vs -94.12% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -16.83% vs -10.46% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 85.02% vs -55.40% in Jun 2025
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






